questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Troubles de la motricité
Syndromes parkinsoniens
Syndromes parkinsoniens : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Syndromes parkinsoniens
Diagnostic médical
Imagerie par résonance magnétique
Évaluation neuropsychologique
Bradykinésie
Tremblements
Maladie de Wilson
Syndromes atypiques
Historique médical
Facteurs de risque
Symptômes
5
Dépression
Troubles du sommeil
Évolution des symptômes
Syndromes parkinsoniens
Perte de l'odorat
Troubles du sommeil
Qualité de vie
Syndromes parkinsoniens
Prévention
5
Prévention
Mode de vie sain
Exercice physique
Santé neurologique
Alimentation
Antioxydants
Facteurs environnementaux
Pesticides
Stress
Progression de la maladie
Traitements
5
Lévodopa
Agonistes de la dopamine
Stimulation cérébrale profonde
Chirurgie
Effets secondaires
Médicaments
Physiothérapie
Ergothérapie
Traitements psychologiques
Symptômes non moteurs
Complications
5
Chutes
Troubles de la déglutition
Troubles cognitifs
Démence
Dépression
Isolement social
Approche multidisciplinaire
Gestion des complications
Facteurs de risque
5
Âge avancé
Antécédents familiaux
Sexe
Syndromes parkinsoniens
Traumatismes crâniens
Facteurs de risque
Exposition professionnelle
Produits chimiques
Maladies auto-immunes
Maladies métaboliques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndromes parkinsoniens : Questions médicales les plus fréquentes",
"headline": "Syndromes parkinsoniens : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndromes parkinsoniens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de la motricité",
"url": "https://questionsmedicales.fr/mesh/D009069",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de la motricité",
"code": {
"@type": "MedicalCode",
"code": "D009069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome parkinsonien secondaire",
"alternateName": "Parkinson Disease, Secondary",
"url": "https://questionsmedicales.fr/mesh/D010302",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome parkinsonien secondaire",
"code": {
"@type": "MedicalCode",
"code": "D010302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Parkinson post-encéphalitique",
"alternateName": "Parkinson Disease, Postencephalitic",
"url": "https://questionsmedicales.fr/mesh/D010301",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Parkinson post-encéphalitique",
"code": {
"@type": "MedicalCode",
"code": "D010301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens",
"alternateName": "Parkinsonian Disorders",
"code": {
"@type": "MedicalCode",
"code": "D020734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sara Hall",
"url": "https://questionsmedicales.fr/author/Sara%20Hall",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Shorena Janelidze",
"url": "https://questionsmedicales.fr/author/Shorena%20Janelidze",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Oskar Hansson",
"url": "https://questionsmedicales.fr/author/Oskar%20Hansson",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Hash Brown Taha",
"url": "https://questionsmedicales.fr/author/Hash%20Brown%20Taha",
"affiliation": {
"@type": "Organization",
"name": "Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Carlo Colosimo",
"url": "https://questionsmedicales.fr/author/Carlo%20Colosimo",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synthesis of Gentamicin Minor Components: Gentamicin C1a and Gentamicin C2b.",
"datePublished": "2022-11-14",
"url": "https://questionsmedicales.fr/article/36375034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.orglett.2c03616"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gentamicin resistance to",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37224563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1139/cjm-2023-0036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intratympanic gentamicin for Ménière's disease.",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36847592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD015246.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Osteomyelitis and Gentamicin-PMMA Chains.",
"datePublished": "2022-08-16",
"url": "https://questionsmedicales.fr/article/35961640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004360"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sub-inhibitory gentamicin pollution induces gentamicin resistance gene integration in class 1 integrons in the environment.",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37244902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-35074-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles de la motricité",
"item": "https://questionsmedicales.fr/mesh/D009069"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndromes parkinsoniens",
"item": "https://questionsmedicales.fr/mesh/D020734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndromes parkinsoniens - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndromes parkinsoniens",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndromes parkinsoniens",
"description": "Comment diagnostiquer un syndrome parkinsonien ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on confondre avec d'autres maladies ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndromes parkinsoniens",
"description": "Quels sont les symptômes moteurs principaux ?\nQuels symptômes non moteurs sont fréquents ?\nComment évoluent les symptômes ?\nY a-t-il des symptômes précoces ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndromes parkinsoniens",
"description": "Peut-on prévenir les syndromes parkinsoniens ?\nQuel rôle joue l'exercice physique ?\nL'alimentation influence-t-elle le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe stress a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndromes parkinsoniens",
"description": "Quels sont les traitements médicamenteux ?\nLa chirurgie est-elle une option ?\nQuels sont les effets secondaires des médicaments ?\nY a-t-il des thérapies complémentaires ?\nComment gérer les symptômes non moteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndromes parkinsoniens",
"description": "Quelles sont les complications courantes ?\nComment les chutes affectent-elles les patients ?\nLes troubles cognitifs sont-ils fréquents ?\nQuelles sont les complications psychologiques ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndromes parkinsoniens",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur ?\nL'exposition professionnelle joue-t-elle un rôle ?\nY a-t-il des liens avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Gentamicins#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un syndrome parkinsonien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes moteurs et non moteurs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM et des évaluations neuropsychologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la bradykinésie, la rigidité et les tremblements au repos."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Wilson ou des syndromes atypiques peuvent être confondues."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes moteurs principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes moteurs incluent la bradykinésie, la rigidité, et les tremblements."
}
},
{
"@type": "Question",
"name": "Quels symptômes non moteurs sont fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes non moteurs incluent la dépression, l'anxiété et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes évoluent progressivement, souvent en s'aggravant avec le temps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes précoces ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la perte de l'odorat ou des troubles du sommeil peuvent apparaître tôt."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent considérablement réduire la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les syndromes parkinsoniens ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé neurologique et retarder l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut réduire le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains pesticides et toxines peut augmenter le risque de Parkinson."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver les symptômes et influencer la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements médicamenteux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la lévodopa, les agonistes de la dopamine et les inhibiteurs de la COMT."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la stimulation cérébrale profonde peut être envisagée pour certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies complémentaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie et l'ergothérapie peuvent aider à améliorer la fonction motrice."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes non moteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements psychologiques et des médicaments peuvent aider à gérer les symptômes non moteurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les chutes, les troubles de la déglutition et les infections."
}
},
{
"@type": "Question",
"name": "Comment les chutes affectent-elles les patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chutes peuvent entraîner des blessures graves, comme des fractures, et réduire l'autonomie."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients développent des troubles cognitifs ou démence au cours de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent souffrir de dépression, d'anxiété et d'isolement social."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus susceptibles de développer des syndromes parkinsoniens."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des liens avec d'autres maladies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes et métaboliques peuvent être associées à un risque accru."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA.
Department of Neurology, David Geffen School of Medicine at UCLA, University of California Los Angeles, 635 Charles E. Young Drive South/Gordon 451, Los Angeles, CA, 90095, USA.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Edmond J. Safra Parkinson Disease Program, Neurology Division, Toronto Western Hospital & Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Mölndal, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
UK Dementia Research Institute at UCL, London, United Kingdom.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Mölndal, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Multimodal Neuroimaging Group, Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Department of Neurology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand. Electronic address: rbh@chulapd.org.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Advanced Brain Monitoring, Inc., Carlsbad, CA, USA. Electronic address: Dan@b-alert.com.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Memory and Aging Center, University of California, San Francisco, CA, USA.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
Publications dans "Syndromes parkinsoniens" :
Gentamicin C1a and the minor isomer C2b have been reported to have favorable properties in terms of antibacterial activity and toxicity compared to the commercial mixture from which they have previous...
Antibiotic overuse and misuse have promoted the emergence and spread of antibiotic-resistant bacteria. Increasing bacterial resistance to antibiotics is a major healthcare problem, necessitating eluci...
Ménière's disease is a condition that causes recurrent episodes of vertigo, associated with hearing loss and tinnitus. Aminoglycosides are sometimes administered directly into the middle ear to treat ...
To evaluate the benefits and harms of intratympanic aminoglycosides versus placebo or no treatment in people with Ménière's disease....
The Cochrane ENT Information Specialist searched the Cochrane ENT Register; Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE; Ovid Embase; Web of Science; ClinicalTrials.gov; ICTRP and ad...
We included randomised controlled trials (RCTs) and quasi-RCTs in adults with a diagnosis of Ménière's disease comparing intratympanic aminoglycosides with either placebo or no treatment. We excluded ...
In chronic osteomyelitis, effective local antibiotic therapy after surgical debridement can be achieved by implantation of gentamicin-PMMA chains. The gentamicin concentrations at the site of infectio...
Antibiotics at sub-inhibitory concentrations are often found in the environment. Here they could impose selective pressure on bacteria, leading to the selection and dissemination of antibiotic resista...
Gentamicin is often used to treat serious paediatric infections. It has been standard practice in Norway to measure the serum concentration of gentamicin immediately prior to the second or third dose ...
This is a retrospective study of routine pre-dose samples obtained for the measurement of serum gentamicin in paediatric patients aged 1 month to 17 years at four hospitals in Norway. Clinical data we...
The most common indications for treatment were febrile urinary tract infection, febrile neutropenia, and suspected or confirmed sepsis. The median (interquartile range) duration of treatment in 353 ep...
An in most cases mildly elevated serum gentamicin concentration was found in the pre-dose sample in 7 of 1,288 treatment episodes. Routine measurement of serum gentamicin via a pre-dose sample should ...
Anaerobic digestion (AD) has been widely employed for converting various biowastes into renewable energy. However, AD of gentamicin mycelial residues (GMRs, a byproduct of gentamicin production) is li...
Complementing our earlier syntheses of the gentamicins B1, C1a, C2b, and X2, we describe the synthesis of gentamicins C1, C2, and C2a characterized by methyl substitution at the 6'-position, and so pr...
Gentamicin is a widely used aminoglycoside with ototoxicity as a known adverse effect. Because of the difficulty in clinical recognition, the prevalence of gentamicin ototoxicity in practice is though...
Single-center, prospective, nonblinded trial....
Inpatient tertiary hospital setting followed by vestibular outpatient clinic review....
Forty-eight patients undergoing a urologic procedure were recruited, with 24 and 17 patients having one or two follow-up tests, respectively, after initial gentamicin administration....
Single dose of gentamicin during a urologic procedure....
Gains for the vestibuloocular reflex (VOR) were measured using the video head impulse test before receiving gentamicin and at two other timepoints after gentamicin. The gains in VOR were then compared...
Before receiving gentamicin, the gains for horizontal VOR were measured for 48 patients. The gains were measured a second time for 24 patients at varying durations postgentamicin (1-56 d) and a third ...
There was no significant effect observed on mean VOR gain decrement after a single dose of gentamicin....
Increasing antibiotic mycelial residues (AMRs) and related antibiotic resistance genes (ARGs) pose a significant threat to ecosystems and public health. Composting is a crucial method for recycling AM...